Image pharmaphorum Editor News FDA 'playbook' aims to prevent hacking of medical devices The FDA has unveiled new guidance outlining how healthcare organisations can prepare their medical devices and staff in the event of a security breach. News Roche buys Tusk, plus cancer immunotherapy drug, for £62m Roche has bought immuno-oncology biotech firm Tusk Therapeutics for an upfront payment of £62 million. News US regulator backs Pfizer's Vizimpro lung cancer drug The US drug regulator has given Pfizer’s Vizimpro the green light in a group of lung cancer patients whose tumours have a certain mutation. News Australians still concerned as My Health Record row continue... The controversial Australian data scheme, My Health Record, continues to spark mixed reactions and uncertainty from professionals and the public. Load more results
News FDA 'playbook' aims to prevent hacking of medical devices The FDA has unveiled new guidance outlining how healthcare organisations can prepare their medical devices and staff in the event of a security breach.
News Roche buys Tusk, plus cancer immunotherapy drug, for £62m Roche has bought immuno-oncology biotech firm Tusk Therapeutics for an upfront payment of £62 million.
News US regulator backs Pfizer's Vizimpro lung cancer drug The US drug regulator has given Pfizer’s Vizimpro the green light in a group of lung cancer patients whose tumours have a certain mutation.
News Australians still concerned as My Health Record row continue... The controversial Australian data scheme, My Health Record, continues to spark mixed reactions and uncertainty from professionals and the public.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
